Astrana Health Q4 2023 EPS $0.26 Up From $(0.08) YoY, Revenue $353M Up From $294.2M YoY
Portfolio Pulse from Benzinga Newsdesk
Astrana Health reported a Q4 2023 EPS of $0.26, a significant increase from the previous year's $(0.08). Revenue for the quarter was $353M, up from $294.2M YoY.

February 27, 2024 | 10:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Astrana Health's Q4 2023 earnings report shows a significant improvement in EPS and revenue, indicating strong financial performance.
The substantial increase in EPS from a negative to a positive value, along with a significant rise in revenue, suggests improved profitability and operational efficiency. This positive financial performance is likely to instill investor confidence and could lead to a short-term uptick in ASTH's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100